Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Clin Liver Dis ; 24(3): 335-350, 2020 08.
Artigo em Inglês | MEDLINE | ID: mdl-32620275

RESUMO

Variceal bleeding is a complication of cirrhosis that defines decompensation. Important advances in the management of gastroesophageal varices have led to a significant decrease in the morbidity and mortality. Achieving these results in clinical practice is contingent on clinicians applying the best practice strategies and appropriate referral to a tertiary center. Several quality metrics were developed by the American Association for the Study of Liver Diseases. This article aims to update outpatient and inpatient strategies to include the latest recommendations on variceal screening and surveillance, primary and secondary prophylaxis of variceal bleeding, and therapy for patients with acute variceal bleeding.


Assuntos
Varizes Esofágicas e Gástricas/etiologia , Varizes Esofágicas e Gástricas/terapia , Hemorragia Gastrointestinal/terapia , Cirrose Hepática/complicações , Antagonistas Adrenérgicos beta/uso terapêutico , Assistência Ambulatorial , Endoscopia Gastrointestinal , Fundo Gástrico , Hemorragia Gastrointestinal/etiologia , Hemorragia Gastrointestinal/prevenção & controle , Hospitalização , Humanos , Ligadura , Cirrose Hepática/fisiopatologia , Prevenção Secundária/métodos
2.
Clin Liver Dis ; 24(2): 175-188, 2020 05.
Artigo em Inglês | MEDLINE | ID: mdl-32245525

RESUMO

Hepatic encephalopathy (HE) is one of the major clinical decompensations of cirrhosis, with a high impact on health care resource utilization and cost. For an effective and comprehensive management of HE, the clinicians need to understand the pathophysiologic mechanisms of HE. This review describes the multiorgan processes involved in HE and how several HE precipitants and treatment strategies act on ammonia production, excretion, and neurotoxicity, including the impact of diabetes and use of cannabinoids. The authors also discuss the current and future role of gut microbiome, systemic/central inflammation, and various neurotransmitters for the pathogenesis and treatment of HE.


Assuntos
Amônia/metabolismo , Astrócitos/fisiologia , Encefalopatia Hepática/etiologia , Encefalopatia Hepática/metabolismo , Amônia/sangue , Animais , Complicações do Diabetes/complicações , Microbioma Gastrointestinal , Ácido Glutâmico/metabolismo , Glutamina/metabolismo , Encefalopatia Hepática/sangue , Histamina/metabolismo , Humanos , Inflamação/sangue , Cirrose Hepática/complicações , Manganês/metabolismo , Microglia/fisiologia , Estresse Oxidativo , Serotonina/metabolismo , Fator de Necrose Tumoral alfa/sangue , Ácido gama-Aminobutírico/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA